logo
  

Horizon Therapeutics Submits Regulatory Filing For UPLIZNA To Treat NMOSD In Brazil

Horizon Therapeutics plc (HZNP) has submitted a regulatory filing to the Brazil
National Health Surveillance Agency for UPLIZNA for the treatment of adult patients with anti-aquaporin-4 immunoglobulin G seropositive neuromyelitis optica spectrum disorder. The company noted that in the N-MOmentum phase 3 trial, UPLIZNA showed a significant reduction in the risk of an NMOSD attack with only two infusions per year, following the initial two loading doses.

UPLIZNA was approved by the FDA in June 2020, by the Japanese Ministry of Health, Labor and Welfare in March 2021 and by the European Commission in April 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hospitality company Hilton has teamed with connected fitness platform Peloton Interactive, Inc. to feature Peloton Bikes across its entire U.S. hotel portfolio. In an industry-first partnership, Hilton's nearly all 5,400 U.S. Hilton-branded hotels will feature at least one Peloton Bike in every fitness center by the end of the year. Australia's central bank raised its benchmark rate by a smaller-than-expected quarter point on Tuesday, after lifting rates by 50 basis points in each of the last four meetings. The policy board of the RBA, headed by Governor Philip Lowe, decided to lift the cash rate target by 25 basis points to 2.60 percent from 2.35 percent. This was the highest rate since July 2013. Unemployment data from Spain and producer prices from the euro area are due on Tuesday, headlining a light day for the European economic news. At 2.00 am ET, the National Institute of Statistics is scheduled to issue Romania's producer prices for August.
Follow RTT